• MJHLS Brand Logo

© 2026 MJH Life Sciences™ and The Center for Biosimilars - Biosimilars, Health Economics & Insights. All rights reserved.

Practice

JAMA Viewpoint Explores Barriers to Biosimilar Uptake for Chronic Diseases

May 2nd 2017

By Christina Mattina

Article

The Uncertainty of BPCIA Litigation Strategies and the "Patent Dance"

May 1st 2017

By Jackie Syrop

Article

Biosimilar Uptake Implies Patient Access to Affordable Medication

April 28th 2017

By The Center for Biosimilars Staff

Article

Who Will Influence Biosimilar Uptake: Physician, Pharmacist, Patient, or Payer?

April 27th 2017

By Carole Ellis

Article

Proposed Xolair Biosimilar Gets FDA Approval for Clinical Trials

April 26th 2017

By Jackie Syrop

Article

EMA Recommends 9 New Medicines, Including Biosimilars

April 25th 2017

By Jackie Syrop

Article

Dr Joseph P Fuhr Sees Need for Education Programs on Biosimilars

April 24th 2017

By The Center for Biosimilars Staff

Article

Patients' Reluctance to Accept Biosimilars Suggests Need for Better Communication, Education

April 20th 2017

By Jackie Syrop

Article

Nebraska Legislature Debates Biosimilar Substitution Bill

April 18th 2017

By Christina Mattina

Article

Prescribers in England Turn to Biosimilar Growth Hormones for Ease of Use, Not Cost

April 14th 2017

By Christina Mattina

Article